Ono Pharmaceutical Co., Ltd./ US6827361030 /
06/06/2024 21:52:14 | Chg. -0.0400 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
4.7300USD | -0.84% | 217,599 Turnover: 1.02 mill. |
-Bid Size: - | -Ask Size: - | 10.89 bill.USD | - | - |
GlobeNewswire
30/05
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancor...
GlobeNewswire
29/05
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DCPH, DPSI, AIRC, ...
GlobeNewswire
20/05
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancor...
GlobeNewswire
13/05
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace...
GlobeNewswire
09/05
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
09/05
Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
09/05
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS, In...
GlobeNewswire
02/05
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
29/04
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp I...
GlobeNewswire
08/04
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highl...
GlobeNewswire
29/02
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highli...
GlobeNewswire
26/02
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates